172 related articles for article (PubMed ID: 28895394)
1. Antineoplastic Agents. 604. The Path of Quinstatin Derivatives to Antibody Drug Conjugates.
Pettit GR; Melody N; Chapuis JC
J Nat Prod; 2017 Sep; 80(9):2447-2452. PubMed ID: 28895394
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic Agents. 605. Isoquinstatins.
Pettit GR; Melody N; Chapuis JC
J Nat Prod; 2018 Mar; 81(3):451-457. PubMed ID: 28926240
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic Agents. 603. Quinstatins: Exceptional Cancer Cell Growth Inhibitors.
Pettit GR; Melody N; Chapuis JC
J Nat Prod; 2017 Mar; 80(3):692-698. PubMed ID: 28211277
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Development of Dolastatin 10-Derived Antibody Drug Conjugate Anticancer Drugs.
Singh SB
J Nat Prod; 2022 Mar; 85(3):666-687. PubMed ID: 35072477
[TBL] [Abstract][Full Text] [Related]
5. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
[TBL] [Abstract][Full Text] [Related]
6. Uncialamycin as a novel payload for antibody drug conjugate (ADC) based targeted cancer therapy.
Chowdari NS; Pan C; Rao C; Langley DR; Sivaprakasam P; Sufi B; Derwin D; Wang Y; Kwok E; Passmore D; Rangan VS; Deshpande S; Cardarelli P; Vite G; Gangwar S
Bioorg Med Chem Lett; 2019 Feb; 29(3):466-470. PubMed ID: 30579797
[TBL] [Abstract][Full Text] [Related]
7. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
[TBL] [Abstract][Full Text] [Related]
8. Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody-drug conjugation.
Yang K; Chen B; Gianolio DA; Stefano JE; Busch M; Manning C; Alving K; Gregory RC; Brondyk WH; Miller RJ; Dhal PK
Org Biomol Chem; 2019 Sep; 17(35):8115-8124. PubMed ID: 31460552
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 600. From the South Pacific Ocean to the silstatins.
Pettit GR; Arce PM; Chapuis JC; Macdonald CB
J Nat Prod; 2015 Mar; 78(3):510-23. PubMed ID: 25688575
[TBL] [Abstract][Full Text] [Related]
10. Antibody-Drug Conjugates.
Kulkarni AA; Gukasyan HJ
Pharm Res; 2015 Nov; 32(11):3451-2. PubMed ID: 26275530
[No Abstract] [Full Text] [Related]
11. Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.
Wang YJ; Li YY; Liu XY; Lu XL; Cao X; Jiao BH
Mar Drugs; 2017 Jan; 15(1):. PubMed ID: 28098746
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as modifiers of antibody-drug conjugate efficacy.
Barok M; Puhka M; Yazdi N; Joensuu H
J Extracell Vesicles; 2021 Feb; 10(4):e12070. PubMed ID: 33613875
[TBL] [Abstract][Full Text] [Related]
13. Antibody-drug conjugates in tumor therapy.
Sammet B; Steinkühler C; Sewald N
Pharm Pat Anal; 2012 Mar; 1(1):65-73. PubMed ID: 24236714
[TBL] [Abstract][Full Text] [Related]
14. Effect of attachment site on stability of cleavable antibody drug conjugates.
Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
[TBL] [Abstract][Full Text] [Related]
15. Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Staudacher AH; Brown MP
Br J Cancer; 2017 Dec; 117(12):1736-1742. PubMed ID: 29065110
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel dolastatin 10 derivatives for versatile conjugations.
Yokosaka S; Izawa A; Sakai C; Sakurada E; Morita Y; Nishio Y
Bioorg Med Chem; 2018 May; 26(8):1643-1652. PubMed ID: 29454703
[TBL] [Abstract][Full Text] [Related]
17. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
Beerli RR; Hell T; Merkel AS; Grawunder U
PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
[TBL] [Abstract][Full Text] [Related]
18. Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload.
Wang Y; Fan S; Zhong W; Zhou X; Li S
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841157
[TBL] [Abstract][Full Text] [Related]
19. Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.
Chen H; Lin Z; Arnst KE; Miller DD; Li W
Molecules; 2017 Aug; 22(8):. PubMed ID: 28763044
[TBL] [Abstract][Full Text] [Related]
20. Conjugations to Endogenous Cysteine Residues.
Nadkarni DV
Methods Mol Biol; 2020; 2078():37-49. PubMed ID: 31643048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
